270 likes | 401 Vues
This comprehensive review explores the current landscape of pulmonary arterial hypertension (PAH) therapy, including historical developments in left heart failure treatments and insights into right ventricular structure and function. Key topics cover the evolution of endpoint-driven clinical trials, challenges faced in trial design, and the role of combination therapies in managing PAH. The synthesis of findings from registries like REVEAL and the implications of immune response dysregulation provide a roadmap for future research and treatment strategies aimed at improving patient outcomes.
E N D